Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.

Diabetes & vascular disease research - 1 Jan 2010

Miller Rachel G, Costacou Tina, Orchard Trevor J

Abstract excerpt

Given the paucity of data in type 1 diabetes concerning lipoprotein-associated phospholipase A( 2) (Lp-PLA(2)), we examined its prospective relationship with coronary artery disease (CAD), as well as the effect of modification by C-reactive protein (CRP) and haptoglobin genotype, in individuals w...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 1-Alkyl-2-acetylglycerophosphocholine Esterase
Share to Albuminuria
Share to C-Reactive Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Coronary Artery Disease

Share to Haptoglobins

Share to Proportional Hazards Models

Source

Open in PubMed Open full text

Identifiers

PMID: 20368232
DOI: 10.1177/1479164109346358
PMCID: PMC2858394

Genes

CAD
CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20368232-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.PMID 20368232Read ↗

Genetic susceptibility to macrovascular complications of type 2 diabetes mellitus.Semantic proximity Read ↗

Lipoprotein(a) and cardiovascular disease in diabetic patientsSemantic proximity Read ↗

When are type 1 diabetic patients at risk for cardiovascular disease?Semantic proximity Read ↗

Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.Semantic proximity Read ↗

Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.Semantic proximity Read ↗

Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).Semantic proximity Read ↗

Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.Semantic proximity Read ↗

Genetic variation of the platelet- surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus.Semantic proximity Read ↗

Lipids, lipoproteins and apolipoprotein (a) isoforms in type 2 diabetic patients.Semantic proximity Read ↗

Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.Semantic proximity Read ↗

Glycaemic control modifies the haptoglobin 2 allele-conferred susceptibility to coronary artery disease in Type 1 diabetes.Semantic proximity Read ↗

Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.